← All indications
Laminopathies
Congenital neuromuscular and muscular dystrophy diseases associated with mutations in the LAMIN TYPE A (Lamin A/C or LMNA gene). It includes CARDIOMYOPATHY, DILATED, 1A; CHARCOT-MARIE-TOOTH DISEASE, type 2B1; EMERY-DREIFUSS MUSCULAR DYSTROPHY, types 2 and 3; HUTCHINSON-GILFORD PROGERIA SYNDROME; LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; Malouf syndrome; Mandibuloacral dysplasia; LMNA-related muscular dystrophy; Restrictive dermopathy, lethal; Heart-hand syndrome, Slovenian type.
Subtype terms (4)
More specific conditions that are subtypes of Laminopathies in the MeSH hierarchy.
- Autosomal Emery-Dreifuss Muscular Dystrophy
- Cardiomyopathy, Dilated
63 drugs (36 approved, 27 experimental)
- Lipodystrophy, Familial Partial
7 drugs (3 approved, 4 experimental)
- Progeria
7 drugs (4 approved, 3 experimental)